Patents by Inventor Sam Campbell

Sam Campbell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for solid tumor treatment
    Patent number: 12390459
    Abstract: Disclosed herein are methods for treating solid tumors by direct injection into the tumors of chemotherapeutic particles, methods for inhibiting tumor metastasis by administering chemotherapeutic particles to a subject having a tumor, and compositions that include chemotherapeutic particles, small amounts of a polysorbate, and a carrier.
    Type: Grant
    Filed: September 12, 2022
    Date of Patent: August 19, 2025
    Assignee: CRITITECH, INC.
    Inventors: Mike Baltezor, Gere diZerega, Charles Decedue, Sam Campbell, Matt McClorey
  • Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
    Patent number: 12329858
    Abstract: Disclosed are combination therapy methods useful for the therapeutic treatment of cancer by combining local administration of compositions containing antineoplastic particles, such as taxane particles, with systemic administration of compositions containing immunotherapeutic agents. Local administration methods include topical application, pulmonary administration, intratumoral injection, intraperitoneal injection, and intracystic injection.
    Type: Grant
    Filed: January 29, 2024
    Date of Patent: June 17, 2025
    Assignee: Crititech, Inc.
    Inventors: Gere S. Dizerega, Michael Baltezor, Sam Campbell, Charles J. Decedue, Matthew McClorey, Holly Maulhardt
  • Treatment of epithelial cysts by intracystic injection of antineoplastic particles
    Patent number: 12128131
    Abstract: Disclosed herein are methods for treating epithelial cysts, including pancreatic cysts, in a subject by intracystic injection of compositions comprising antineoplastic particles, including taxane particles such as paclitaxel particles and docetaxel particles.
    Type: Grant
    Filed: July 13, 2023
    Date of Patent: October 29, 2024
    Assignee: CRITITECH, INC.
    Inventors: Gere S. diZerega, Michael Baltezor, Charles J. Decedue, Sam Campbell, Matthew McClorey, Marc Iacobucci, Holly Maulhardt
  • Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
    Publication number: 20240252441
    Abstract: Disclosed are combination therapy methods useful for the therapeutic treatment of cancer by combining local administration of compositions containing antineoplastic particles, such as taxane particles, with systemic administration of compositions containing immunotherapeutic agents. Local administration methods include topical application, pulmonary administration, intratumoral injection, intraperitoneal injection, and intracystic injection.
    Type: Application
    Filed: January 29, 2024
    Publication date: August 1, 2024
    Inventors: Gere S. DIZEREGA, Michael BALTEZOR, Sam CAMPBELL, Charles J. DECEDUE, Matthew MCCLOREY, Holly MAULHARDT
  • Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
    Patent number: 11918691
    Abstract: Disclosed are combination therapy methods useful for the therapeutic treatment of cancer by combining local administration of compositions containing antineoplastic particles, such as taxane particles, with systemic administration of compositions containing immunotherapeutic agents. Local administration methods include topical application, pulmonary administration, intratumoral injection, intraperitoneal injection, arid intracystic injection.
    Type: Grant
    Filed: January 13, 2023
    Date of Patent: March 5, 2024
    Assignee: CRITITECH, INC.
    Inventors: Gere S. Dizerega, Michael Baltezor, Sam Campbell, Charles J. Decedue, Matthew McClorey, Holly Maulhardt
  • Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles
    Publication number: 20230372234
    Abstract: Disclosed herein are methods for treating epithelial cysts, including pancreatic cysts, in a subject by intracystic injection of compositions comprising antineoplastic particles, including taxane particles such as paclitaxel particles and docetaxel particles.
    Type: Application
    Filed: July 13, 2023
    Publication date: November 23, 2023
    Inventors: Gere S. diZerega, Michael Baltezor, Charles J. Decedue, Sam Campbell, Matthew McClorey, Marc Iacobucci, Holly Maulhardt
  • Treatment of epithelial cysts by intracystic injection of antineoplastic particles
    Patent number: 11737972
    Abstract: Disclosed herein are methods for treating epithelial cysts, including pancreatic cysts, in a subject by intracystic injection of compositions comprising antineoplastic particles, including taxane particles such as paclitaxel particles and docetaxel particles.
    Type: Grant
    Filed: October 12, 2022
    Date of Patent: August 29, 2023
    Assignee: CRITITECH, INC.
    Inventors: Gere S. diZerega, Michael Baltezor, Charles J. Decedue, Sam Campbell, Matthew McClorey, Marc Iacobucci, Holly Maulhardt
  • Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
    Publication number: 20230263731
    Abstract: Disclosed are combination therapy methods useful for the therapeutic treatment of cancer by combining local administration of compositions containing antineoplastic particles, such as taxane particles, with systemic administration of compositions containing immunotherapeutic agents. Local administration methods include topical application, pulmonary administration, intratumoral injection, intraperitoneal injection, arid intracystic injection.
    Type: Application
    Filed: January 13, 2023
    Publication date: August 24, 2023
    Inventors: Gere S. DIZEREGA, Michael BALTEZOR, Sam CAMPBELL, Charles J. DECEDUE, Matthew MCCLOREY
  • METHODS FOR SOLID TUMOR TREATMENT
    Publication number: 20230172927
    Abstract: Disclosed herein are methods for treating solid tumors by direct injection into the tumors of chemotherapeutic particles, methods for inhibiting tumor metastasis by administering chemotherapeutic particles to a subject having a tumor, and compositions that include chemotherapeutic particles, small amounts of a polysorbate, and a carrier.
    Type: Application
    Filed: September 12, 2022
    Publication date: June 8, 2023
    Inventors: Mike Baltezor, Gere diZerega, Charles Decedue, Sam Campbell, Matt McClorey
  • Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles
    Publication number: 20230111288
    Abstract: Disclosed herein are methods for treating epithelial cysts, including pancreatic cysts, in a subject by intracystic injection of compositions comprising antineoplastic particles, including taxane particles such as paclitaxel particles and docetaxel particles.
    Type: Application
    Filed: October 12, 2022
    Publication date: April 13, 2023
    Inventors: Gere S. diZerega, Michael Baltezor, Charles J. Decedue, Sam Campbell, Matthew McClorey, Marc Iacobucci, Holly Maulhardt
  • Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
    Patent number: 11583499
    Abstract: Disclosed are combination therapy methods useful for the therapeutic treatment of cancer by combining local administration of compositions containing antineoplastic particles, such as taxane particles, with systemic administration of compositions containing immunotherapeutic agents. Local administration methods include topical application, pulmonary administration, intratumoral injection, intraperitoneal injection, and intracystic injection.
    Type: Grant
    Filed: May 28, 2021
    Date of Patent: February 21, 2023
    Assignee: CritiTech, Inc.
    Inventors: Gere S. Dizerega, Michael Baltezor, Sam Campbell, Charles J. Decedue, Matthew McClorey
  • Treatment of epithelial cysts by intracystic injection of antineoplastic particles
    Patent number: 11523983
    Abstract: Disclosed herein are methods for treating epithelial cysts, including pancreatic cysts, in a subject by intracystic injection of compositions comprising antineoplastic particles, including taxane particles such as paclitaxel particles and docetaxel particles.
    Type: Grant
    Filed: May 10, 2021
    Date of Patent: December 13, 2022
    Assignee: CritiTech, Inc.
    Inventors: Gere S. diZerega, Michael Baltezor, Charles J. Decedue, Sam Campbell, Matthew McClorey, Marc Iacobucci, Holly Maulhardt
  • Methods for solid tumor treatment
    Patent number: 11458133
    Abstract: Disclosed herein are methods for treating solid tumors by direct injection into the tumors of chemotherapeutic particles, methods for inhibiting tumor metastasis by administering chemotherapeutic particles to a subject having a tumor, and compositions that include chemotherapeutic particles, small amounts of a polysorbate, and a carrier.
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: October 4, 2022
    Assignee: CritiTech, Inc.
    Inventors: Mike Baltezor, Gere diZerega, Charles Decedue, Sam Campbell, Matt McClorey
  • Treatment of Bladder Cancer by Local Administration of Taxane Particles
    Publication number: 20220096423
    Abstract: Disclosed herein are methods for treating and inhibiting the recurrence of bladder cancer by local administration of compositions comprising taxane particles such as docetaxel particles. Administration methods include intratumoral injection, direct injection into surgical tumor resection sites, and intravesical instillation.
    Type: Application
    Filed: October 1, 2021
    Publication date: March 31, 2022
    Inventors: Gere S. DIZEREGA, Michael BALTEZOR, Charles DECEDUE, Sam CAMPBELL, Matthew MCCLOREY
  • Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
    Publication number: 20220047513
    Abstract: Disclosed are combination therapy methods useful for the therapeutic treatment of cancer by combining local administration of compositions containing antineoplastic particles, such as taxane particles, with systemic administration of compositions containing immunotherapeutic agents. Local administration methods include topical application, pulmonary administration, intratumoral injection, intraperitoneal injection, and intracystic injection.
    Type: Application
    Filed: May 28, 2021
    Publication date: February 17, 2022
    Inventors: Gere S. DIZEREGA, Michael BALTEZOR, Sam CAMPBELL, Charles J. DECEDUE, Matthew MCCLOREY
  • Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles
    Publication number: 20210259959
    Abstract: Disclosed herein are methods for treating epithelial cysts, including pancreatic cysts, in a subject by intracystic injection of compositions comprising antineoplastic particles, including taxane particles such as paclitaxel particles and docetaxel particles.
    Type: Application
    Filed: May 10, 2021
    Publication date: August 26, 2021
    Inventors: Gere S. diZerega, Michael Baltezor, Charles J. Decedue, Sam Campbell, Matthew McClorey, Marc Iacobucci, Holly Maulhardt
  • METHODS FOR ISOLATING TUMOR-SPECIFIC IMMUNE CELLS FROM A SUBJECT FOR ADOPTIVE CELL THERAPY AND CANCER VACCINES
    Publication number: 20210214683
    Abstract: Disclosed are methods for the isolation of tumor-specific immune cells from subjects that have a malignant tumor and have received local administration of a composition comprising taxane particles to the malignant tumor, and use of such isolated immune cells in compositions for adoptive cell therapy and cancer vaccines.
    Type: Application
    Filed: April 12, 2019
    Publication date: July 15, 2021
    Inventors: Gere S. DIZEREGA, Holly MAULHARDT, Michael BALTEZOR, Sam CAMPBELL, Charles J. DECEDUE, William JOHNSTON, Matthew MCCLOREY, James VERCO
  • Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
    Patent number: 11058639
    Abstract: Disclosed are combination therapy methods useful for the therapeutic treatment of cancer by combining local administration of compositions containing antineoplastic particles, such as taxane particles, with systemic administration of compositions containing immunotherapeutic agents. Local administration methods include topical application, pulmonary administration, intratumoral injection, intraperitoneal injection, and intracystic injection.
    Type: Grant
    Filed: March 30, 2020
    Date of Patent: July 13, 2021
    Assignee: CritiTech, Inc.
    Inventors: Gere S. Dizerega, Michael Baltezor, Sam Campbell, Charles J. Decedue, Matthew McClorey
  • Methods for solid tumor treatment
    Patent number: 11033542
    Abstract: Disclosed herein are methods for treating solid tumors by direct injection into the tumors of chemotherapeutic particles, methods for inhibiting tumor metastasis by administering chemotherapeutic particles to a subject having a tumor, and compositions that include chemotherapeutic particles, small amounts of a polysorbate, and a carrier.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: June 15, 2021
    Assignee: CritiTech, Inc.
    Inventors: Mike Baltezor, Gere diZerega, Charles Decedue, Sam Campbell, Matt McClorey
  • Methods for solid tumor treatment
    Patent number: 10894045
    Abstract: Disclosed herein are methods for treating solid tumors by direct injection into the tumors of chemotherapeutic particles, methods for inhibiting tumor metastasis by administering chemotherapeutic particles to a subject having a tumor, and compositions that include chemotherapeutic particles, small amounts of a polysorbate, and a carrier.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: January 19, 2021
    Assignee: Crititech, Inc.
    Inventors: Mike Baltezor, Gere diZerega, Charles Decedue, Sam Campbell, Matt McClorey